Literature DB >> 15750073

Typing of Saccharomyces cerevisiae clinical strains by using microsatellite sequence polymorphism.

J Y Malgoire1, S Bertout, F Renaud, J M Bastide, M Mallié.   

Abstract

It seems that S. cerevisiae, which was thought for about 30 years to be a nonpathogenic yeast, should now be considered an opportunistic pathogen. In this study, we estimated the discrimination ability of the microsatellite sequence amplification technique within a sample of clinical and reference S. cerevisiae strains and S. boulardii reference strains.

Entities:  

Mesh：

Year:  2005        PMID： 15750073      PMCID： PMC1081240          DOI： 10.1128/JCM.43.3.1133-1137.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

Review 1.  Possible role of catheters in Saccharomyces boulardii fungemia.

Authors:  C Hennequin; C Kauffmann-Lacroix; A Jobert; J P Viard; C Ricour; J L Jacquemin; P Berche
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-01       Impact factor: 3.267

2.  Molecular monitoring of wine fermentations conducted by active dry yeast strains.

Authors:  A Querol; E Barrio; T Huerta; D Ramón
Journal:  Appl Environ Microbiol       Date:  1992-09       Impact factor: 4.792

3.  Saccharomyces boulardii is not Saccharomyces cerevisiae.

Authors:  L V McFarland
Journal:  Clin Infect Dis       Date:  1996-01       Impact factor: 9.079

4.  Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients.

Authors:  Arnoldo J Riquelme; Mario A Calvo; Ana M Guzmán; María S Depix; Patricia García; Carlos Pérez; Marco Arrese; Jaime A Labarca
Journal:  J Clin Gastroenterol       Date:  2003-01       Impact factor: 3.062

5.  Microsatellite typing as a new tool for identification of Saccharomyces cerevisiae strains.

Authors:  C Hennequin; A Thierry; G F Richard; G Lecointre; H V Nguyen; C Gaillardin; B Dujon
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  Are live saccharomyces yeasts harmful to patients?

Authors:  R Piarroux; L Millon; K Bardonnet; O Vagner; H Koenig
Journal:  Lancet       Date:  1999-05-29       Impact factor: 79.321

7.  Postoperative peritonitis due to Saccharomyces cerivisiae--treated with ketoconazole.

Authors:  D M Canafax; H J Mann; S H Dougherty
Journal:  Drug Intell Clin Pharm       Date:  1982-09

8.  Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.).

Authors:  M J McCullough; K V Clemons; J H McCusker; D A Stevens
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  The spectrum of non-Candida fungal infections following bone marrow transplantation.

Authors:  V A Morrison; R J Haake; D J Weisdorf
Journal:  Medicine (Baltimore)       Date:  1993-03       Impact factor: 1.889

10.  Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy.

Authors:  J D Sobel; J Vazquez; M Lynch; C Meriwether; M J Zervos
Journal:  Clin Infect Dis       Date:  1993-01       Impact factor: 9.079
View more
  7 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

Review 2.  Comparative genomics and molecular dynamics of DNA repeats in eukaryotes.

Authors:  Guy-Franck Richard; Alix Kerrest; Bernard Dujon
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

Review 3.  Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives.

Authors:  Jean-Paul Buts
Journal:  Dig Dis Sci       Date:  2008-06-05       Impact factor: 3.199

4.  Genome-wide association analysis of clinical vs. nonclinical origin provides insights into Saccharomyces cerevisiae pathogenesis.

Authors:  L A H Muller; J E Lucas; D R Georgianna; J H McCusker
Journal:  Mol Ecol       Date:  2011-08-31       Impact factor: 6.185

5.  Microsatellite analysis of genetic diversity among clinical and nonclinical Saccharomyces cerevisiae isolates suggests heterozygote advantage in clinical environments.

Authors:  Ludo A H Muller; John H McCusker
Journal:  Mol Ecol       Date:  2009-05-20       Impact factor: 6.185

6.  Population genomics of the pathogenic yeast Candida tropicalis identifies hybrid isolates in environmental samples.

Authors:  Caoimhe E O'Brien; João Oliveira-Pacheco; Eoin Ó Cinnéide; Max A B Haase; Chris Todd Hittinger; Thomas R Rogers; Oscar Zaragoza; Ursula Bond; Geraldine Butler
Journal:  PLoS Pathog       Date:  2021-03-31       Impact factor: 6.823

7.  Whole Genome Analysis of 132 Clinical Saccharomyces cerevisiae Strains Reveals Extensive Ploidy Variation.

Authors:  Yuan O Zhu; Gavin Sherlock; Dmitri A Petrov
Journal:  G3 (Bethesda)       Date:  2016-08-09       Impact factor: 3.154
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.